Gamida Cell Profit Margin

The latest profit margin for GMDA is -826.1% as of March 2024. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Gamida Cell's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, GMDA currently prints -826.1% for profit margin, while the sector average sits near 21.34%. That is roughly 3972.0% below the sector mean. Large gaps often invite a closer look at Gamida Cell's growth, margins, and balance sheet.

Profit Margin shows how effectively Gamida Cell converts resources into returns. At -826.1%, GMDA may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting GMDA's profit margin (-826.1%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Gamida Cell's profit margin against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.